Newswise — In studies with mouse and human tissue, as well as live mice, Johns Hopkins Medicine researchers report that a snag in the normal process of cleaning up broken DNA in brain cells may hasten the progression of Parkinson’s disease. Specifically, the researchers found that a protein dubbed “STING” responds to clean-up signals in brain cells damaged by Parkinson’s disease by creating a cycle of inflammation that may accelerate the disease’s progression.
The findings, published April 4 in the Proceedings of the National Academies of Science, could advance the search for drugs and new drug targets to stop or slow the progression of Parkinson’s disease.
Parkinson’s disease is a neurodegenerative disorder marked by the buildup of a misfolded protein, called alpha-synuclein, in brain cells. As more misshapen proteins clump together, they kill off brain cells called dopamine neurons, leaving behind large swaths of dead brain matter. As these brain cells die, they impair a person’s ability to move, think or regulate emotions. Previous studies showed that as brain cells are damaged by alpha-synuclein clumps, they release pieces of damaged DNA into the nerve cell’s body.
“Freely floating DNA is not good for neurons, so the immune system has evolved ways to clear it out,” says Ted Dawson, M.D., Ph.D., director of the Johns Hopkins Institute for Cell Engineering and professor of neurology at the Johns Hopkins University School of Medicine.
As part of this immune response, the STING protein — STING stands for stimulator of interferon genes — initiates a cascade of inflammatory chemical signals that bring immune cells to the site to clean up the damaged DNA. While this response may be beneficial to destroying viruses and bacteria in the rest of the body, the researchers suspect such an inflammatory response in the brain may disrupt the delicate balance of brain cell signals, leading to a worsening of Parkinson’s disease.
